The genome-wide association (GWA) study is an increasingly popular way to attempt to identify the causal variants in human disease. Duplicate genotyping (or re-genotyping) a portion of the samples in a GWA study is common, though it is typical for these data to be ignored in subsequent tests of genetic association. We demonstrate a method for including duplicate genotype data in linear trend tests of genetic association which yields increased power. We also consider the cost-effectiveness of collecting duplicate genotype data and find that when the relative cost of genotyping to phenotyping and sample acquisition costs is less than or equal to the genotyping error rate it is more powerful to duplicate genotype the entire sample instead of spending the same money to increase the sample size. Duplicate genotyping is particularly costeffective when SNP minor allele frequencies are low. Practical advice for the implementation of duplicate genotyping is provided. Free software is provided to compute asymptotic and permutation based tests of association using duplicate genotype data as well as to aid in the duplicate genotyping design decision.
Introduction
Genetic tests of association often utilize case-control study designs in order to identify possible genetic factors contributing to the etiology of a complex disease (Amos 2007 , Sasieni 1997 . Examining the whole genome simultaneously through genome-wide association (GWA) studies has become an increasingly popular and effective method of determining genetic association. While high costs of GWA studies are still a limiting factor, they continue to become more economically plausible with advances in technology that identify single nucleotide polymorphism (SNP) genotypes at decreasing costs (Amos 2007) .
Despite these technological advances, the misclassification of genotypes by SNP technology (genotyping errors) remains a persistent issue. Genotyping error rates are low in many instances (~0.1-0.2% or lower; Saunders et al. 2007 , Tintle et al. 2005 , Fridley et al. 2008 , Heid et al. 2008 , Pompanon et al. 2005 . However, these error rates are not uniform across all SNPs and some SNPs have measurably larger genotyping error rates (Pompanon et al. 2005) . The impact of genotyping errors on case-control tests of genotype-phenotype association is well known. Specifically, non-differential errors (genotyping error rates are the same regardless of phenotype) have no effect on type I error, but do cause inflated type II error (i.e. reduce power) (Gordon & Ott 2001 , Gordon et al. 2002 , Ahn et al. 2007 . Genotyping errors are particularly detrimental to power when the minor SNP allele frequency is low (Gordon et al. 2002 , Ahn et al. 2007 , Kang et al. 2004 .
In addition to laboratory and technology-based approaches to reducing genotyping errors, which seek to address errors at their source, some have proposed the consideration of genotyping errors when designing the study. For example, double sampling ) uses a perfect genotype mechanism (like gene sequencing) on a subset of the sample. Another recent paper discusses how to incorporate genotyping errors when optimizing a two-stage design (Zuo et al. 2008) . A third approach involves replicate genotyping (Fridley et al. 2008 , Rice & Holmans 2003 , Tintle et al. 2007 , Lai et al. 2007 , Bonin et al. 2004 , which means genotyping a random subset of individuals in the sample two or more times, instead of only once.
Duplicate genotyping has been proposed by many for quality control reasons (e.g. Rice & Holmans 2003 , Bonin et al. 2004 and it is now a fairly common practice (Tintle et al. 2005 , Fridley et al. 2008 . Traditionally, duplicate genotype data were ignored in the subsequent statistical analyses. The data were simply used as an initial assessment of data quality. Recently, however, a method was proposed to incorporate duplicate genotype data in standard 2 2 χ tests of genotype-phenotype association on 2x3 tables (Tintle et al. 2007 ).
Subsequently, Tintle et al. (to appear) demonstrated the cost-effectiveness of duplicate genotyping (i.e. more power) for use in 2 2 χ tests when genotyping costs are low relative to phenotyping and sample acquisition costs. It was found that, as a general rule, duplicate genotyping the entire sample increases power when relative genotype to phenotype/sample acquisition costs don't exceed the genotyping error rate. Additionally, when the minor SNP allele frequency is low, duplicate genotyping the entire sample can be cost-effective even when relative costs are greater than the genotyping error rate.
The linear trend test of association (LTT), first proposed by Cochran (1954) and Armitage (1955) , has been suggested by many (Sasieni 1997 , Slager & Schaid 2001 , Freidlin et al. 2002 , Zheng et al. 2003 , Zheng & Gastwirth 2006 as a method for analyzing SNP genotype data since it can incorporate information about the disease mode of inheritance, and thus increase statistical power by narrowing the focus of the alternative hypothesis. Recently, Ahn et al. (2007) demonstrated the impact of genotyping errors on the LTT. Also, Gordon et al. (2007) demonstrated how to use the LTT when double sample data are collected. In this paper, we demonstrate how to include duplicate genotype data in a LTT. We also explore the utility of including duplicate genotype data in subsequent tests of association if they have been collected for quality control reasons. Lastly, we evaluate the cost-effectiveness of designing a study to collect duplicate genotype data for analysis with the LTT.
Methods

Sampling Strategy
We consider a sampling strategy where a fraction of the entire sample,
), is randomly selected to be genotyped exactly twice, while the remaining fraction of the sample, (1-r), is genotyped exactly once. We assume that all samples have been phenotyped as either a "case" or a "control."
Genotyping Error Assumptions 1. Let ε i,j be the probability of an individual of genotype i being classified as genotype j. Following the error model of Douglas et al. (2002) , we assume that ε 1,2 = ε 2,1 = ε 2,3 = ε 3,2 and ε 1,3 = ε 3,1 = 0.
2. We assume non-differential genotyping errors, meaning that the probability of genotyping errors is the same for each individual in the sample, regardless of case or control status.
3. We assume that genotyping error probabilities are independent and remain constant from the first to second genotyping. Specifically, we mean that the probability of a genotyping error does not change for an individual's second genotyping, and is not dependent upon whether they were incorrectly genotyped the first time.
Notation
= m δ the frequency of allele m at the SNP marker. In this paper we assume the SNP is bi-allelic, and, thus, m=U,V. We also assume that the SNP marker allele associated with the disease is allele 2.
= n ζ the frequency of risk allele n at the disease locus. In this paper we assume the disease locus is bi-allelic and we denote the risk allele as B and the nonrisk allele as A. Thus, n=A,B. 
φ = the disease prevalence in the population. Thus, BB f is the probability someone who is BB at the disease locus (homozygote for the risk allele) has the disease, AB f is the probability someone who is AB at the disease locus (heterozygote for the risk allele) has the disease, and AA f is the probability someone who is AA at the disease locus (homozygote for the non-risk allele) has the disease. When a fraction (r) of the sample has been duplicate genotyped, and the SNP marker under consideration has three possible genotypes (1=UU, 2=UV and 3=VV), data can be summarized into two tables, as shown in Tables 1a and 1b. We assume that an equal fraction of both cases and controls has been duplicate genotyped. 
where j i ≠ and k i ≠ , with a similar equation for the controls. As in shown in Tintle et al. (2007) , using equal weights (0.5) for the inconsistently identified individuals is optimal. then the null hypothesis of no association between genotype and disease is true.
Linear Trend Test
As noted earlier, the linear trend test (LTT) is a powerful choice for the analysis of case-control studies of genetic association because of the ability to include information about the disease mode of inheritance (Sasieni 1997 , Slager & Schaid 2001 , Zheng & Gastwirth 2006 Tintle et al. (2007) to place individuals who have been inconsistently duplicate genotyped to each of the two genotypes to which they have been genotyped (see Equation (1)). This strategy, however, means that the resulting contingency table of phenotype-genotype (Table 1c ) no longer has a multinomial distribution due to increased covariance between cells, requiring the introduction of the LTT d .
In developing the LTT d , we also address the issue of bias in the U σ estimate. Freidlin et al. (2002) demonstrated that the method of estimating U σ as considered by Slager and Schaid (2001) was biased and thus provided invalid results. Zheng and Gastwirth (2006) consider two alternatives to the Slager and Schaid approach which they call "case-control" (cc) and "control" (c). The Slager and Schaid method estimates U σ assuming that the null hypothesis of no genotype-phenotype association is true. The cc method estimates U σ without the restriction of the null hypothesis being true, whereas the c method is similar but only uses the sample of controls. Zheng and Gastwirth find, and we confirmed in our own attempts to implement the method, that the c method increases the type I error in some cases (results not shown). Thus, we choose to base our results only on the cc method.
Simulation Study
To confirm that the empirical distribution of the LTT d (Derived later, see Results:
Finding the LTT d statistic) follows the theoretical asymptotic distribution ( 2 1 χ ) for practical sample sizes we conducted a simulation study (see Table 2 for parameters and values used). We examined all possible combinations of parameter values and so a total of 17,496 settings were evaluated. The simulation study was conducted as follows:
Step 1. For given values of V δ , B ζ , ρ, φ, γ, and the disease MOI the true genotype probabilities (p i and q i , i=1,2,3) were computed. See Ahn et al. (2007) for details.
Step 2. Table 2 , 2,000 random tables were simulated. In cases where γ=1 (null hypothesis is true), the type I error rate was analyzed by comparing the nominal significant level α (we examined 0.05, 0.005, and 0.0002) with the empirical α level. In cases where γ=1.25 or γ=2.00 (i.e. the alternative hypothesis is true), the empirical power was compared to the theoretical power (see equation (A3) in the Appendix).
Cost-effectiveness Computational Study
We completed a computational study comparing theoretical power values for different values of r (duplicate genotyping percentage), c (relative genotyping costs) and other parameters. Table 3 shows the settings used for this study. We examined all 10,368 possible combinations of parameter values based on Table 3 . The computational study was carried out as follows:
Step 1. Assuming there are no genotyping errors, for given values of V δ , B ζ , ρ, φ, γ and the disease type, the genotype probabilities were computed as if no duplicates were obtained. These values were then used to find the sample size needed (N 0 ) to yield the specified power level (80% or 95%).
Step 2. Find the budget (B) needed to conduct the study if no duplicates as: B=(1+c)N 0 , where c is the genotyping cost per person relative to phenotyping/acquisition cost.
Step 3. Assuming there is duplicate genotyping (r>0), the sample size that can be obtained for the same budget, B, is found as
. N r can then be used in the power computation formula (A3) in the Appendix, to find the power using duplicate genotyping for that sample size. Then we find the optimal value of r that yields the largest power of the test. All computations used α=0.0002.
Results
Finding the LTT d Statistic
Zheng and Gastwirth (2006) 
and V is an estimate of the variance of U. Tintle et al. (2007) showed that by using the allocation strategy (Equation (1)) Tables 1a and 1c estimate the same quantities. Thus, the numerator of the Zheng and Gastwirth Z statistic becomes:
According to the Central Limit Theorem, Table 1c has an approximately multivariate normal distribution (see also Tintle et al. 2007 ). The expected value of U d under the null hypothesis (p Equation (A2) also accounts for additional covariance between cells in Table 1c from using the allocation strategy.
Simulation Results for LTT d
As described earlier (Methods: Simulation study), a simulation study was conducted to ensure that nominal type I and type II error rates obtained using the asymptotic theory of the LTT d were maintained in practice. 
Simulation Results for LTT d under the Null Hypothesis
For each combination of parameter values, a 99% confidence interval was found for the empirical α. For both the dominant and additive models, nominal type I error rates were maintained empirically regardless of sample size since an expected number of simulation settings had a 99% confidence interval on the empirical α that did not contain the nominal α (1.2% and 1.2% for dominant and additive, respectively, for α=0.05, 1.2% and 1.3% for the α=0.005 level and 1.1% and 0.7% for the α=0.0002 level). Nominal type I error rates were maintained empirically for the recessive model as long as the minimum cell count in Table 1c was at least 5 (detailed results not shown).
Simulation Results for LTT d under the Alternative Hypothesis
The LTT d statistic generally gives comparable theoretical and empirical power values across all simulation settings for the additive and dominant models as long as expected cell counts in Table 1c are at least 5. For each combination of parameter values, a 99% confidence interval was placed on the empirical power. For both the dominant and additive models when the minimum cell count in Table  3 was at least 5, an expected number of simulation settings had a 99% confidence interval on the empirical power that did not contain the theoretical power (0.9% and 1.2% for dominant and additive, respectively, for α=0.05, 1.3% and 0.9% for α=0.005 level and 1.7% and 1.3% for the α=0.0002 level). When the minimum cell count was less than 5 in the dominant and additive models, the empirical power was often still very close to theoretical power (results not shown). The recessive model with small V δ showed significant differences between theoretical and empirical power (detailed results not shown), though theoretical power and empirical power were similar for larger values of V δ .
Recommendations for Use of a Permutation Test
Based on the simulation study, differences in theoretical and empirical type I and type II errors are possible when the recessive disease model is used, in cases where at least one cell count in the grouped table is less than 5, or in cases where the total sample is less than 1,000 individuals. In these cases we recommend estimating p-values for the LTT d by permuting phenotype status instead of using 10 Statistical Applications in Genetics and Molecular Biology, Vol. 8 [2009 ], Iss. 1, Art. 24 DOI: 10.2202 /1544 -6115.1433 the asymptotic theory provided above. A permutation based p-value is available in our software (see Results: Software).
Example
In Tintle et al. (2007) , duplicate genotype data from a case-control study on bipolar disorder was presented for a SNP with inconsistently genotyped individuals where all individuals were duplicate genotyped. We present this data here ( 
Cost-effectiveness of Duplicate Genotyping Using Previously Collected Data
Initially, we consider an instance of including previously collected quality control data in the test of association. In every case examined, the power of the LTT d is higher when the duplicate genotype data is included as compared to when it is not. In other words, it is better to include the duplicate genotype data in subsequent tests of association then to ignore inconsistencies and treat the data as missing. This result is consistent with the results of Tintle et al. (2007) for the 2 2 χ test of association.
Evaluating the Cost-effectiveness of Collecting Duplicate Genotype Data
The most important case, however, is when c>0. That is, when we view the collection of duplicate genotype data as an a priori design decision, and thus must account for the cost of collecting the duplicates for a fraction, r, of the sample.
Given a fixed budget, in 49.2% of cases examined (see Table 3 ) where c>0, duplicate genotyping the entire sample (r=1) was found to be the most costeffective design strategy (yields the highest power). In all remaining cases, r=0 provided the highest power. Thus, the optimal strategy is always "all or nothing."
In order to characterize situations where duplicate genotyping will be costeffective, logistic regression models were used with all parameters predicting whether or not duplicate genotyping the entire sample was the most cost-effective design. Three parameters ( V δ , c and ε) had the strongest relationship with costeffectiveness. Relative cost, c, had the strongest relationship (Wald χ 2 =1424.2, p<0.0001), genotyping error rate ε also had a very strong relationship (Wald χ 2 =1259.2, p<0.0001) and minor allele frequency ( V δ ) was also strongly related (Wald χ 2 =465.6, p<0.0001). As minor allele frequency ( V δ ) declined, costs (c) declined, or genotyping error rate (ε) increased, duplicate genotyping the entire sample was more likely to be the optimal design decision. Table 5 shows the percentage of cases examined in the computational study where duplicate genotyping the entire sample is the most effective design decision for different values of c (relative genotyping costs) and ε (genotyping error rate). Table 5 demonstrates a general rule of thumb: duplicate genotyping the entire sample will always be cost-effective (regardless of V δ ) if c ≤ ε. Example Power Values Table 6 provides power values for a specific example. Specifically, we present power under different values of V δ , ε, r and c for a disease with a prevalence of 2.5%, disease allele frequency of 5%, equal number of cases and controls (k=1), and a SNP marker and disease allele that are in perfect linkage disequilibrium ( ρ =1). The sample size needed to yield 80% power was calculated assuming there was no genotyping error. Column III shows the power for that sample size, after taking the genotyping error into account. When the marker frequency is low and/or the genotyping error rate is larger Column III demonstrates that power can be significantly impacted by genotyping errors. Columns IV-VII then reduce the sample size to maintain the budget reflecting the additional cost of collecting duplicate genotype data on all samples at different genotype costs (c). As c decreases, ε increases and V δ decreases, Columns IV-VIII demonstrate that 13 duplicate genotyping becomes more cost-effective. We note that in all cases duplicate genotyping does not meet or exceed the error-free power of 80% (detailed results not shown) however duplicate genotyping can successfully mediate some of the power loss due to genotyping errors.
Note that the power values in Table 6 are from a specific example. Please use our software (Results: Software) to investigate power at values specific to your research situation while keeping in mind the rule of thumb presented in Table 5 .
Recommendations for Use
In practice, duplicate genotyping should be considered when relative genotype to phenotype/sample acquisition costs do not exceed the expected SNP genotyping error rate. A more detailed treatment of practical considerations when using duplicate genotyping is provided in Tintle et al. (to appear) . We summarize three main considerations here.
First, calculations provided in this manuscript consider only a single SNP. However, in practice, the decision to duplicate genotype will need to be made for an entire set of SNPs (e.g. all of the SNPs on a chip). In these cases using the same rule of thumb (duplicate genotype if c ≤ ε) is appropriate where the ε used is the minimum error rate expected for any single SNP.
Second, if there is concern that some samples may be of low quality and, thus, have higher genotyping error rates than other samples (a violation of genotyping error assumption #2), the error rate, ε, used in the c ≤ ε rule of thumb should be the minimum expected ε for the high quality samples. Note, however, that we are still assuming non-differential errors in this case. Differential errors may increase the type I error rate, and are not considered in this manuscript.
Third, GWA studies are typically conducted in two-stages where all markers are genotyped on a sample of individuals, and then a subset of the markers is genotyped on a sample of additional individuals. When considering the use of duplicate genotyping in two-stage studies, the decision on the use of duplicate genotyping should be made separately at each stage since the relative cost of genotyping to phenotyping will be different at each stage.
Software
To facilitate the utilization of the methods discussed in this paper, we provide two companion pieces of software for this work. The first computes the LTT d statistic and provides an asymptotic and permutation p-value. The second provides power computations for different genotyping costs, allele frequencies and error rates to assist in the duplicate genotyping design decision. Software is available at http://math.hope.edu/tintle/duplicate.html (source code written in R).
Conclusions
This work demonstrates how duplicate genotype data can be included in a linear trend test (LTT) of genetic association. Duplicate genotype data are included in the LTT through a weighting strategy and a subsequent adjustment of the variance of the LTT statistic yielding the LTT d . We demonstrate via simulation that the asymptotic null and alternative distributions of the LTT d statistic are obtained with reasonably small sample sizes in most cases. Both asymptotic and permutation test p-values are available in the free companion software.
We demonstrate that in the case of no duplicate genotyping costs (e.g. the data has already been collected) including the duplicate data in the LTT d always increases statistical power. This confirms a similar result in Tintle et al. (2007) .
We also consider the cost-effectiveness of designing a study to collect duplicate genotype data, and find that when the relative cost of genotyping to phenotype/sample acquisition costs (c) is less than or equal to the genotyping error rate (ε), collecting duplicate genotype data on the entire sample is costeffective. Further, we find that the optimal amount of duplicate genotyping, in these cases, will always involve duplicate genotyping the entire sample. In a twostage GWA study for a complex disease, if a relatively small set of SNPs are being followed up at stage 2 and it will be costly to enroll more subjects, duplicate genotyping may be cost-effective since relative genotyping to phenotyping/acquisition costs c will be low.
Since the rule-of-thumb just described is conservative it is important to note that duplicate genotyping will be cost-effective in many situations when c>ε. This rule was provided to allow researchers to quickly assess the costeffectiveness of duplicate genotyping on a large scale. It is quite likely that, even if c>ε, duplicate genotyping may provide moderate power gains for SNPs with low minor SNP allele frequency. Our software should be used to determine costeffectiveness of duplicate genotyping for specific experimental conditions. We assume that genotyping errors are independent from the first to second genotyping (genotyping error assumption #3) and that genotyping error rates are non-differential (genotyping error assumption #2). Future work is needed to extend results to consider differential genotyping errors when duplicate genotyping. Further reading on sources of genotyping error and their impact on analyses can be found in Bonin et al. (2004) and Gordon and Finch (2005) . We also assume that duplicate genotyping is applied to a random subsample of size nr. Further work is necessary to explore optimizing the value of r depending upon phenotype or initial genotype classification.
When collected, duplicate genotype data should always be included in the subsequent test of association and in many realistic cases duplicate genotype data should be collected on the entire sample. ( ) Genetics and Molecular Biology, Vol. 8 [2009] 
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